Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Operating Leases (2019 - 2021)

Historic Operating Leases for Cogent Biosciences (COGT) over the last 3 years, with Q3 2021 value amounting to $1.4 million.

  • Cogent Biosciences' Operating Leases fell 6104.04% to $1.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.4 million, marking a year-over-year decrease of 6104.04%. This contributed to the annual value of $3.2 million for FY2020, which is 2850.67% down from last year.
  • As of Q3 2021, Cogent Biosciences' Operating Leases stood at $1.4 million, which was down 6104.04% from $2.0 million recorded in Q2 2021.
  • In the past 5 years, Cogent Biosciences' Operating Leases registered a high of $5.6 million during Q1 2019, and its lowest value of $1.4 million during Q3 2021.
  • Moreover, its 3-year median value for Operating Leases was $3.7 million (2020), whereas its average is $3.7 million.
  • Per our database at Business Quant, Cogent Biosciences' Operating Leases tumbled by 2359.76% in 2020 and then crashed by 6104.04% in 2021.
  • Quarter analysis of 3 years shows Cogent Biosciences' Operating Leases stood at $4.4 million in 2019, then decreased by 28.51% to $3.2 million in 2020, then plummeted by 54.42% to $1.4 million in 2021.
  • Its Operating Leases stands at $1.4 million for Q3 2021, versus $2.0 million for Q2 2021 and $2.6 million for Q1 2021.